IDEXX Laboratories Stock

IDEXX Laboratories Current Liabilities

The Current Liabilities of IDEXX Laboratories (IDXX) as of Aug 13, 2026 is 1.72 B USD. In the previous year, Current Liabilities was 1.58 B USD — a change of 8.81% (higher).

Current Liabilities

1.72 BUSD

YoY

8.81%

Last updated:

Current Liabilities of IDEXX Laboratories is 2026 1.72 B USD. Current Liabilities of IDEXX Laboratories was 2025 1.58 B USD. It decreases by 8.81% higher compared to the previous year.
Access this data via the Eulerpool API

IDEXX Laboratories Stock analysis

What does IDEXX Laboratories do? The history of IDEXX Laboratories Inc began in 1983 when a research team from the University of Maine developed technology for the automatic analysis of animal blood. The first products were soon sold and the company grew rapidly. Today, IDEXX is a leading global provider of veterinary diagnostic and IT solutions, recognized by customers in over 175 countries. IDEXX's business model is based on innovation and a comprehensive understanding of the needs of veterinarians and their patients. The company offers a wide range of products and solutions that make the diagnosis and treatment of animal diseases easier and more reliable. These include tests and devices for blood analysis, urine and stool diagnostics, as well as imaging, infection control, and cancer diagnostics. The company has several divisions that focus on different aspects of veterinary diagnostics. IDEXX Diagnostics is the largest business segment, offering veterinary lab services, diagnostic tests, and software solutions. IDEXX Water is a company specializing in the analysis of water samples and monitoring of environmental conditions. IDEXX Livestock, the newest division of IDEXX, provides veterinary solutions for agricultural and livestock operations. Key products of IDEXX include tests for parasites, infections, diabetes, and kidney function. The company has also developed some innovative products, such as SNAP tests, which provide fast and accurate results and can perform tests for various pathogens simultaneously. IDEXX is also a company committed to sustainability. The IDEXX Foundation was established in 2013 and has since donated over $32 million to local and global projects that aim to protect animals and the environment. Overall, IDEXX Laboratories Inc is a company specialized in veterinary diagnostic and IT solutions to support veterinarians in treating animals. The wide range of solutions and products, as well as the commitment to sustainability, make the company an important player in the market for veterinary diagnostics. IDEXX Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IDEXX Laboratories stock

Current Liabilities of IDEXX Laboratories is 1.72 B USD in 2026.

Current Liabilities of IDEXX Laboratories changed from 1.58 B USD to 1.72 B USD, representing a 8.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities IDEXX Laboratories since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's IDEXX Laboratories historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — IDEXX Laboratories

All Key Metrics — IDEXX Laboratories